ArticleNanomaterials (Basel, Switzerland)2021

Engineering Modular Half-Antibody Conjugated Nanoparticles for Targeting CD44v6-Expressing Cancer Cells.

Bianca N Lourenço et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.